Ruocong Zhao

958 total citations
15 papers, 532 citations indexed

About

Ruocong Zhao is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Ruocong Zhao has authored 15 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Ruocong Zhao's work include CAR-T cell therapy research (12 papers), Immune Cell Function and Interaction (6 papers) and Virus-based gene therapy research (3 papers). Ruocong Zhao is often cited by papers focused on CAR-T cell therapy research (12 papers), Immune Cell Function and Interaction (6 papers) and Virus-based gene therapy research (3 papers). Ruocong Zhao collaborates with scholars based in China, United Kingdom and Hong Kong. Ruocong Zhao's co-authors include Peng Li, Qiting Wu, Le Qin, Yao Yao, Yangqiu Li, Duanqing Pei, Xuchao Zhang, Simiao Lin, Yunxin Lai and Xinru Wei and has published in prestigious journals such as SHILAP Revista de lepidopterología, Free Radical Biology and Medicine and Frontiers in Immunology.

In The Last Decade

Ruocong Zhao

14 papers receiving 525 citations

Peers

Countries citing papers authored by Ruocong Zhao

Since Specialization

Citations

This map shows the geographic impact of Ruocong Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruocong Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruocong Zhao more than expected).

Fields of papers citing papers by Ruocong Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruocong Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruocong Zhao. The network helps show where Ruocong Zhao may publish in the future.

Co-authorship network of co-authors of Ruocong Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Ruocong Zhao. A scholar is included among the top collaborators of Ruocong Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruocong Zhao. Ruocong Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	The high efficacy of claudin18.2-targeted CAR-T cell therapy in advanced pancreatic cancer with an antibody-dependent safety strategy 2025 ·Molecular Therapy ·(unknown), Xiaomin Zhang, Ruocong Zhao, (unknown), Chenguang Wang, (unknown), (unknown), Ke Hu, (unknown), Bochen Zhao, Xianhao Liu, (unknown), Lei Chen, Yisheng Li, (unknown)	4
2	Insufficient S-sulfhydration of cAMP-response element binding protein 1 participates in hyperhomocysteinemia or cisplatin induced kidney fibrosis via promoting epithelial-mesenchymal transition 2025 ·Free Radical Biology and Medicine ·(unknown), Ke Xue, Ruocong Zhao, (unknown), Xinyu Zhu, (unknown), Yuqing Ding, Lijia Xu, Wen Wang	0
3	Disruption of CISH promotes the antitumor activity of human T cells and decreases PD-1 expression levels 2022 ·Molecular Therapy — Oncolytics ·Jiang Lv, (unknown), Ruocong Zhao, Di Wu, Zhiping Wu, Diwei Zheng, Siyu Li, (unknown), Qiting Wu, Youguo Long, Zhaoyang Tang, Yan‐Lai Tang, Xue‐Qun Luo, Yao Yao, (unknown), Peng Li	23
4	BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia 2022 ·Cell Death and Disease ·(unknown), (unknown), Ruocong Zhao, (unknown), Cunte Chen, (unknown), Xibao Yu, (unknown), (unknown), Xin Liu, (unknown), Shaohua Chen, Yuhong Lu, Zhi Yu, Liang Wang, Peng Li, Chengwu Zeng, Yangqiu Li	41
5	CD318 is a target of chimeric antigen receptor T cells for the treatment of colorectal cancer 2022 ·Clinical and Experimental Medicine ·Ming Li, Shanglin Li, Ruocong Zhao, Jiang Lv, Diwei Zheng, Le Qin, Siyu Li, Qiting Wu, Youguo Long, Zhaoyang Tang, Yan‐Lai Tang, Lihua Yang, Yao Yao, Xue‐Qun Luo, Peng Li	10
6	Human Hyaluronidase PH20 Potentiates the Antitumor Activities of Mesothelin-Specific CAR-T Cells Against Gastric Cancer 2021 ·Frontiers in Immunology ·Ruocong Zhao, (unknown), (unknown), Shanglin Li, Jiang Lv, Qiting Wu, Youguo Long, Suna Wang, Yao Yao, Wei Wei, Jie Yang, Bin-Chao Wang, Zhenfeng Zhang, Hui Zeng, Yangqiu Li, Peng Li	50
7	PSCA is a target of chimeric antigen receptor T cells in gastric cancer 2020 ·Biomarker Research ·Di Wu, Jiang Lv, Ruocong Zhao, Zhiping Wu, Diwei Zheng, Jingxuan Shi, Simiao Lin, Suna Wang, Qiting Wu, Youguo Long, Peng Li, Yao Yao	34
8	Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growth 2020 ·Biomarker Research ·Le Qin, Ruocong Zhao, (unknown), Xinru Wei, Qiting Wu, Youguo Long, Zhiwu Jiang, Yangqiu Li, (unknown), Xuchao Zhang, Yi‐Long Wu, Shuzhong Cui, Wei Wei, Huihui Yao, Zixia Liu, Su Mei Cao, Yao Yao, Zhenfeng Zhang, Peng Li	51
9	Current status and hurdles for CAR-T cell immune therapy 2019 ·SHILAP Revista de lepidopterología ·Ruocong Zhao, (unknown), Shanglin Li, (unknown), Peng Li	7
10	DNAX-activating protein 10 co-stimulation enhances the anti-tumor efficacy of chimeric antigen receptor T cells 2018 ·OncoImmunology ·Ruocong Zhao, Lin Cheng, Zhiwu Jiang, Xinru Wei, Baiheng Li, Qiting Wu, Suna Wang, Simiao Lin, Youguo Long, Xuchao Zhang, Yi‐Long Wu, Xin Du, Duanqing Pei, Pentao Liu, Yangqiu Li, Shuzhong Cui, Yao Yao, Peng Li	26
11	PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells 2017 ·OncoImmunology ·Xinru Wei, Yunxin Lai, Jin Li, Le Qin, (unknown), Ruocong Zhao, Baiheng Li, Simiao Lin, Suna Wang, Qiting Wu, (unknown), Muyun Peng, Fenglei Yu, Yangqiu Li, Xuchao Zhang, Yi‐Long Wu, Pentao Liu, Duanqing Pei, Yao Yao, Peng Li	106
12	Incorporation of functional elements enhances the antitumor capacity of CAR T cells 2017 ·Experimental Hematology and Oncology ·Le Qin, Ruocong Zhao, Peng Li	19
13	Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T Cells 2017 ·Leukemia ·Yunxin Lai, Jianyu Weng, (unknown), Le Qin, Peilong Lai, Ruocong Zhao, Zhiwu Jiang, (unknown), Shudong Lin, Shixiang Wang, Qiting Wu, Zhaoyang Tang, (unknown), Duanqing Pei, Yikun Yao, Xin Du, Peng Li	78
14	Incorporation of a hinge domain improves the expansion of chimeric antigen receptor T cells 2017 ·Journal of Hematology & Oncology ·Le Qin, Yunxin Lai, Ruocong Zhao, Xinru Wei, Jianyu Weng, Peilong Lai, Baiheng Li, Simiao Lin, Suna Wang, Qiting Wu, (unknown), Yangqiu Li, Xuchao Zhang, Yi‐Long Wu, Pentao Liu, Yao Yao, Duanqing Pei, Xin Du, Peng Li	79
15	Mechanisms determining the fate of hematopoietic stem cells. 2015 ·PubMed ·Shouheng Lin, Ruocong Zhao, Yiren Xiao, Peng Li	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact